aTyr Pharma
ATYR
#9471
Rank
HK$0.62 B
Marketcap
HK$6.35
Share price
0.95%
Change (1 day)
-75.18%
Change (1 year)

Revenue for aTyr Pharma (ATYR)

Revenue in 2025 (TTM): HK$1.47 Million

According to aTyr Pharma's latest financial reports the company's current revenue (TTM ) is HK$1.47 Million. In 2024 the company made a revenue of HK$1.82 Million a decrease over the revenue in the year 2023 that were of HK$2.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for aTyr Pharma from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$1.47 M-18.96%
2024 HK$1.82 M-33.82%
2023 HK$2.75 M-96.6%
2022 HK$81.14 M
2021 N/A-100%
2020 HK$81.04 M2366.06%
2019 HK$3.28 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Veracyte
VCYT
HK$3.85 B 260,500.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$91.19 B 6,170,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA